Avantec Vascular Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Avantec Vascular Corporation's estimated annual revenue is currently $14.3M per year.
- Avantec Vascular Corporation's estimated revenue per employee is $251,000
Employee Data
- Avantec Vascular Corporation has 57 Employees.
- Avantec Vascular Corporation grew their employee count by 4% last year.
Avantec Vascular Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Director Finance | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Assistant R&D Manager | Reveal Email/Phone |
4 | Production Supervisor | Reveal Email/Phone |
5 | Quality Assurance Specialist II | Reveal Email/Phone |
6 | President & CEO | Reveal Email/Phone |
7 | QA Specialist | Reveal Email/Phone |
8 | Quality Assurance Specialist | Reveal Email/Phone |
9 | Senior Quality Engineer | Reveal Email/Phone |
10 | Principle R&D Engineer | Reveal Email/Phone |
Avantec Vascular Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Avantec Vascular Corporation?
Avantec Vascular is dedicated to advancing vascular therapies through innovation. Avantec is a rapidly growing, privately held corporation that develops, manufactures and markets innovative products for the treatment of vascular disease. The company's focus is developing products for the treatment of Coronary Artery Disease (CAD). Avantec's initial products include the Duraflexâ„¢ Coronary Stent System and the Apolloâ„¢ Coronary Dilatation Catheter. In addition, Avantec is developing a number of advanced technology platforms. Within interventional cardiology, a primary area of focus is the development of the company's proprietary drug eluting stent system. Avantec Vascular Corporation's products are not available for sale in the United States.
keywords:N/AN/A
Total Funding
57
Number of Employees
$14.3M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.3M | 57 | -5% | N/A |
#2 | $5.2M | 57 | -17% | N/A |
#3 | $7.2M | 57 | 0% | N/A |
#4 | $16.4M | 57 | 4% | $16.3M |
#5 | $7.6M | 58 | 29% | N/A |